Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Precision BioSciences Inc has a consensus price target of $23.2 based on the ratings of 6 analysts. The high is $60 issued by HC Wainwright & Co. on May 21, 2025. The low is $1 issued by Goldman Sachs on November 10, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 21, 2025, March 28, 2025, and March 19, 2025, respectively. With an average price target of $60 between HC Wainwright & Co., there's an implied 1107.24% upside for Precision BioSciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/21/2025 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
03/28/2025 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
03/19/2025 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
02/19/2025 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
01/10/2025 | Buy Now | 584.1% | BMO Capital | Kostas Biliouris34% | $34 → $34 | Upgrade | Market Perform → Outperform | Get Alert |
01/10/2025 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
08/22/2024 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
05/30/2024 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
04/30/2024 | Buy Now | 282.29% | Guggenheim | Debjit Chattopadhyay52% | → $19 | Initiates | → Buy | Get Alert |
04/17/2024 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
03/28/2024 | Buy Now | 1107.24% | HC Wainwright & Co. | Patrick Trucchio47% | $3 → $60 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | -39.64% | HC Wainwright & Co. | Patrick Trucchio47% | → $3 | Reiterates | Buy → Buy | Get Alert |
09/19/2023 | Buy Now | -39.64% | HC Wainwright & Co. | Patrick Trucchio47% | → $3 | Reiterates | Buy → Buy | Get Alert |
08/17/2023 | Buy Now | -39.64% | HC Wainwright & Co. | Patrick Trucchio47% | $5 → $3 | Maintains | Buy | Get Alert |
08/07/2023 | Buy Now | — | HC Wainwright & Co. | Patrick Trucchio47% | — | Reiterates | → Buy | Get Alert |
07/28/2023 | Buy Now | -59.76% | BTIG | Thomas Shrader39% | $6 → $2 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | 0.6% | HC Wainwright & Co. | Patrick Trucchio47% | $17 → $5 | Reiterates | Buy → Buy | Get Alert |
06/01/2023 | Buy Now | 242.05% | HC Wainwright & Co. | Patrick Trucchio47% | → $17 | Reiterates | Buy → Buy | Get Alert |
03/15/2023 | Buy Now | 242.05% | HC Wainwright & Co. | Patrick Trucchio47% | → $17 | Reiterates | → Buy | Get Alert |
03/14/2023 | Buy Now | -19.52% | BMO Capital | Kostas Biliouris34% | $7 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
11/10/2022 | Buy Now | -79.88% | Goldman Sachs | Salveen Richter53% | $2 → $1 | Maintains | Neutral | Get Alert |
11/10/2022 | Buy Now | 242.05% | HC Wainwright & Co. | Patrick Trucchio47% | $20 → $17 | Maintains | Buy | Get Alert |
08/09/2022 | Buy Now | -59.76% | Goldman Sachs | Salveen Richter53% | $3 → $2 | Maintains | Neutral | Get Alert |
06/17/2022 | Buy Now | 40.85% | BMO Capital | Kostas Biliouris34% | → $7 | Initiates | → Outperform | Get Alert |
06/09/2022 | Buy Now | — | William Blair | Raju Prasad18% | — | Downgrade | Outperform → Market Perform | Get Alert |
The latest price target for Precision BioSciences (NASDAQ:DTIL) was reported by HC Wainwright & Co. on May 21, 2025. The analyst firm set a price target for $60.00 expecting DTIL to rise to within 12 months (a possible 1107.24% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Precision BioSciences (NASDAQ:DTIL) was provided by HC Wainwright & Co., and Precision BioSciences reiterated their buy rating.
The last upgrade for Precision BioSciences Inc happened on January 10, 2025 when BMO Capital raised their price target to $34. BMO Capital previously had a market perform for Precision BioSciences Inc.
The last downgrade for Precision BioSciences Inc happened on March 14, 2023 when BMO Capital changed their price target from $7 to $4 for Precision BioSciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precision BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precision BioSciences was filed on May 21, 2025 so you should expect the next rating to be made available sometime around May 21, 2026.
While ratings are subjective and will change, the latest Precision BioSciences (DTIL) rating was a reiterated with a price target of $60.00 to $60.00. The current price Precision BioSciences (DTIL) is trading at is $4.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.